Reckitt Benckiser Group plc Sponsored ADR logo

Reckitt Benckiser Group plc Sponsored ADR (RBGLY)

Market Closed
17 Jul, 20:00
OTC PINK OTC PINK
$
13. 75
-0.13
-0.9366%
$
43.06B Market Cap
18.91 P/E Ratio
255.6% Div Yield
715,900 Volume
0 Eps
$ 13.88
Previous Close
Investors:
Add Transaction
Day Range
13.69 13.88
Year Range
12.02 17.8
Want to track RBGLY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Reckitt Benckiser: Cheap Again, I'm Going In

Reckitt Benckiser: Cheap Again, I'm Going In

Reckitt Benckiser is experiencing a market overreaction to the downside, creating an attractive entry point below £46/share. RBGLY's recent share price decline is driven by temporary macro headwinds—oil price sensitivity and a weak cold/flu season—not by fundamental business weakness. I have rebased my valuation to a 15x P/E multiple, lowering my price target to £46/share, and now rate the stock a 'Buy.'

Seekingalpha | 1 month ago
Reckitt Benckiser Bets on AI to Speed Innovation and Boost Growth

Reckitt Benckiser Bets on AI to Speed Innovation and Boost Growth

Reckitt Benckiser Group LON: RKT executives used an investor “Focus On” event to outline how the company is applying digital science, artificial intelligence and predictive modeling across its innovation process, saying the capabilities are intended to support faster product development, stronger launch execution and efficiency gains.

Marketbeat | 2 months ago
Reckitt Benckiser Group plc (RBGLY) Q1 2026 Sales/Trading Call Transcript

Reckitt Benckiser Group plc (RBGLY) Q1 2026 Sales/Trading Call Transcript

Reckitt Benckiser Group plc (RBGLY) Q1 2026 Sales/Trading Call Transcript

Seekingalpha | 2 months ago
Reckitt stock dips on Q1 miss: what's really ailing the health giant?

Reckitt stock dips on Q1 miss: what's really ailing the health giant?

Reckitt stock fell about 5% in early trading on Wednesday after the consumer goods group said first-quarter core like-for-like net revenue rose only 1.3%. The figure was well below the 2.9% analysts had expected, and warned that first-half adjusted operating margin would be roughly 200 basis points lower than a year earlier.

Invezz | 2 months ago
Reckitt's Like-for-Like Revenue Rises on Emerging Markets Performance

Reckitt's Like-for-Like Revenue Rises on Emerging Markets Performance

Lysol maker Reckitt Benckiser booked a rise in first-quarter like for like revenue, helped by strong emerging markets performance, where like-for-like sales grew 7.6%.

Wsj | 2 months ago
New Strong Sell Stocks for April 10th

New Strong Sell Stocks for April 10th

RBGLY, SOUHY and SUNS have been added to the Zacks Rank #5 (Strong Sell) List on April 10, 2026.

Zacks | 3 months ago
Reckitt Benckiser: Cheap Again Amid Macro Concerns

Reckitt Benckiser: Cheap Again Amid Macro Concerns

Reckitt Benckiser remains a 'Buy' despite near-term macro uncertainty from the Iran War and weak consumer sentiment. RBGLY's core business has been doing fine, with solid growth in emerging markets offsetting lackluster performance in Europe. At a trailing price-to-earnings ratio of 14.5, RBGLY trades at a significant discount to U.S. peers despite strong profitability and reasonable leverage.

Seekingalpha | 4 months ago
Reckitt Benckiser Group (OTCMKTS:RBGLY) Stock Price Crosses Below Two Hundred Day Moving Average   – Here’s Why

Reckitt Benckiser Group (OTCMKTS:RBGLY) Stock Price Crosses Below Two Hundred Day Moving Average – Here’s Why

Reckitt Benckiser Group PLC (OTCMKTS:RBGLY - Get Free Report)'s share price passed below its two hundred day moving average during trading on Thursday. The stock has a two hundred day moving average of $15.95 and traded as low as $14.11. Reckitt Benckiser Group shares last traded at $14.13, with a volume of 733,330 shares

Defenseworld | 4 months ago
Reckitt Benckiser Group plc (RBGLY) Q4 2025 Earnings Call Transcript

Reckitt Benckiser Group plc (RBGLY) Q4 2025 Earnings Call Transcript

Reckitt Benckiser Group plc (RBGLY) Q4 2025 Earnings Call Transcript

Seekingalpha | 4 months ago
Reckitt beats its own targets and signals confidence in 2026 after year of strategic progress

Reckitt beats its own targets and signals confidence in 2026 after year of strategic progress

Consumer health group delivers core growth ahead of medium-term guidance as emerging markets surge and Essential Home disposal completes Reckitt Benckiser Group PLC (LSE:RKT, FRA:3RB, XETRA:3RB), the maker of Dettol, Nurofen and Durex, said it looks forward "with confidence" after a year in which its core business grew faster than its own medium-term targets, and promised to sustain that momentum into 2026. The company guided for Core Reckitt like-for-like (LFL) net revenue growth within its 4% to 5% medium-term range for 2026, despite flagging a weaker cold and flu season in the first quarter and a continued difficult trading environment in Europe.

Proactiveinvestors | 4 months ago
Lysol Maker Reckitt Books Rise in Revenue, Boosted by Emerging Markets

Lysol Maker Reckitt Books Rise in Revenue, Boosted by Emerging Markets

The Lysol disinfectant maker's sales grew 5% on a like-for-like basis on year, Reckitt Benckiser said.

Wsj | 4 months ago
Reckitt to pay £1.6bn special dividend after Essential Home sale

Reckitt to pay £1.6bn special dividend after Essential Home sale

Reckitt Benckiser Group PLC (LSE:RKT, XETRA:3RB) has unveiled plans to hand back about £1.6 billion to shareholders through a one-off special dividend, following the sale of its Essential Home business. The consumer goods group said it intends to pay a special dividend of 235 pence a share after completing the disposal of the division to Advent International, a deal announced at the end of December.

Proactiveinvestors | 6 months ago
Loading...
Load More